Scarica l'app Stockscreener
2.26
1.71%
0.06
Precedente Chiudi:
$2.20
Aprire:
$2.265
Volume 24 ore:
96,276
Relative Volume:
0.11
Capitalizzazione di mercato:
$7.23M
Reddito:
-
Utile/perdita netta:
$-11.27M
Rapporto P/E:
-0.1055
EPS:
-21.4132
Flusso di cassa netto:
$-9.40M
1 W Prestazione:
-1.86%
1M Prestazione:
-20.08%
6M Prestazione:
-66.30%
1 anno Prestazione:
-84.13%
Intervallo 1D:
$2.13
$2.2975
Intervallo di 1 settimana:
$2.03
$2.70
Portata 52W:
$1.58
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Nome
Dermata Therapeutics Inc
Settore
Industria
Telefono
(858)-223-0882
Indirizzo
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Confronta DRMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
2.26 | 7.04M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.75 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.46 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.49 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
802.65 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.15 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dermata Therapeutics Inc Borsa (DRMA) Ultime notizie
Dermata Therapeutics Inc Equity Warrant Stock Analysis and ForecastBullish Engulfing Patterns & Free Phenomenal Capital Appreciation - earlytimes.in
Pre-market Movers: RSLS, STSS, VERO, KTTA... - RTTNews
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Dermata Therapeutics announces $2.55M private offering - MSN
Top 5 stocks to watch today | December 30th - MSN
Dermata Therapeutics: Is Change on the Horizon? - StocksToTrade
Dermata Therapeutics: Unveiling Bold Moves - timothysykes.com
Top 5 Stocks To Watch Today | December 30th - MSN
Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus - Benzinga
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Dermata stock surges after closing $4.1 million private placement By Investing.com - Investing.com Australia
Dermata stock surges after closing $4.1 million private placement - Investing.com
Dermata Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Weatherford Democrat
Skincare firm Dermata raises $4.1M to back new over-the-counter acne kit - Stock Titan
Bank Watch: Why Dermata Therapeutics Inc Equity Warrant stock is popular among millennialsQuarterly Profit Report & High Accuracy Investment Entry Signals - moha.gov.vn
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Fox21Online
Dermata Therapeutics, Inc.Warrant (NQ: DRMAW - FinancialContent
Dermata Therapeutics’ Skincare Innovation Sparks Interest - StocksToTrade
Dermata Therapeutics, Inc. (DRMA) Stock: Surges 25% as Insider-Backed $4.1M Offering Fuels Momentum - parameter.io
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Why Is Dermata Therapeutics Stock Surging Wednesday? - Sahm
Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today? - Menafn.com
Dermata Therapeutics stock soars after securing $4.1 million private placement By Investing.com - Investing.com Nigeria
Dermata Therapeutics stock soars after securing $4.1 million private placement - Investing.com Nigeria
DRMA Stocks Thrive: Time for Action? - timothysykes.com
Why did Dermata Therapeutics stock surge 22% pre-market today? - MSN
Dermata lines up as much as $12.4M to help launch OTC acne kit - Stock Titan
Ingersoll (500210) Stock RalliesVolume Profile Analysis & Investment Recommendations You Can Trust - Bollywood Helpline
Dermata Therapeutics, Inc. announced that it expects to receive $4.124468 million in funding - marketscreener.com
Can Dermata Therapeutics Inc. Equity Warrant stock deliver consistent earnings growthTrade Volume Report & Smart Money Movement Alerts - Улправда
Quarterly Risk: How interest rate cuts could boost ESGRO stockJuly 2025 Market Mood & Free Verified High Yield Trade Plans - Улправда
Will Dermata Therapeutics Inc. stock reach all time highs in 20252025 Trading Volume Trends & Stock Portfolio Risk Management - Улправда
How buybacks impact Dermata Therapeutics Inc. stock valueLayoff News & Community Supported Trade Ideas - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock could rally in 2025Quarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда
Is Dermata Therapeutics Inc. stock vulnerable to regulatory risksJuly 2025 Intraday Action & Expert Approved Trade Ideas - Улправда
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Intraday Action & Stock Portfolio Risk Control - Улправда
Will Dermata Therapeutics Inc. stock split again soonJuly 2025 Macro Moves & Precise Swing Trade Alerts - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock is popular among millennialsTake Profit & Weekly Watchlist for Hot Stocks - DonanımHaber
Will Dermata Therapeutics Inc. stock outperform growth indexesWeekly Trade Review & Expert Curated Trade Setups - DonanımHaber
Why Dermata Therapeutics Inc. Equity Warrant stock remains undervaluedCEO Change & Weekly High Potential Alerts - Bölüm Sonu Canavarı
Will Dermata Therapeutics Inc. stock attract more institutional investorsJuly 2025 Momentum & Comprehensive Market Scan Reports - DonanımHaber
Growth Value: Will Dermata Therapeutics Inc. Equity Warrant stock gain from lower inflation2025 Macro Impact & Low Volatility Stock Recommendations - DonanımHaber
Dermata Therapeutics Earnings Notes - Trefis
Support Test: Will Dermata Therapeutics Inc. stock deliver shareholder valueJuly 2025 Gainers & Accurate Intraday Trading Signals - DonanımHaber
Does POWL stock trade at a discount to peers2025 EndofYear Setup & Daily Technical Stock Forecast Reports - Bollywood Helpline
Dermata Therapeutics Inc Azioni (DRMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.44%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):